Blog — Page 25

Heerim Architects (037440) Stock Outlook 2026: Overseas Order Momentum and the Labor-Intensive Design Trap

Heerim Architects (037440) Stock Outlook 2026: Overseas Order Momentum and the Labor-Intensive Design Trap

Heerim Architects and Planners (KOSDAQ 037440) 2026 stock outlook. A deep qualitative look at its architecture design, CM and supervision model, Middle East airport and stadium order momentum, backlog-driven revenue recognition, thin margins of a people-heavy service business, and FX and geopolitical order-cycle risk for global investors.

Heerim 037440 architecture design
Architect Professional Liability (E and O) Insurance Cost 2026: Premium Drivers, Claims-Made Traps, and How to Pick Limits

Architect Professional Liability (E and O) Insurance Cost 2026: Premium Drivers, Claims-Made Traps, and How to Pick Limits

What architect professional liability and E and O insurance actually covers, why the claims-made structure creates gaps that end careers, how retroactive dates and tail coverage work, what really drives your premium, realistic 2026 cost ranges, and the mistakes that void a policy right when you need it.

architect insurance professional liability E and O insurance
Ozempic Gastroparesis Lawsuit 2026: The Two Fights That Actually Decide a Semaglutide Case

Ozempic Gastroparesis Lawsuit 2026: The Two Fights That Actually Decide a Semaglutide Case

The Ozempic and Wegovy gastroparesis lawsuit doesn't turn on whether you were injured — it turns on the warning label and on whether your stomach paralysis came from the drug or from diabetes. Here is the semaglutide-specific playbook: eligibility, MDL 3094's Novo Nordisk track, objective evidence, settlement value drivers, choosing counsel, and the statute of limitations.

Ozempic Gastroparesis Semaglutide
Depo-Provera Brain Tumor Lawsuit 2026: Who Qualifies, What Cases Are Worth, and How to File

Depo-Provera Brain Tumor Lawsuit 2026: Who Qualifies, What Cases Are Worth, and How to File

A practical 2026 guide to the Depo-Provera meningioma lawsuit: who qualifies after long-term medroxyprogesterone use, the status of MDL 3140, the medical records you need, how mass-tort settlement value is estimated by injury tier, the step-by-step claim process, contingency fees, and the statute-of-limitations mistakes that sink otherwise strong cases.

Depo-Provera lawsuit meningioma brain tumor
Kyung Chang Industrial (002420) Stock Outlook 2026: Betting the Transmission Cash Cow Against the EV Parts Mix

Kyung Chang Industrial (002420) Stock Outlook 2026: Betting the Transmission Cash Cow Against the EV Parts Mix

A 2026 stock outlook for Kyung Chang Industrial (KRX 002420), the Korean auto-parts maker behind transmission components, control cables and pedals for Hyundai and Kia. We weigh the structural decline of transmission parts against cables, electronic pedals and EV reduction-gear opportunities, plus OEM production-cycle risk, thin margins and the deep-value case.

002420 Kyung Chang Industrial Korea Stocks
KCTC (KRX 009070) Stock Outlook 2026: Port Stevedoring, 3PL, Heavy-Cargo Cycles and the Deep-Value Asset Play

KCTC (KRX 009070) Stock Outlook 2026: Port Stevedoring, 3PL, Heavy-Cargo Cycles and the Deep-Value Asset Play

KCTC (KRX 009070) 2026 stock outlook. A qualitative deep dive into its port stevedoring, third-party logistics (3PL) and heavy-cargo project business, container and bulk throughput cycles, wage and fuel margin pressure, its low-PBR asset base, competition with CJ Logistics, Hanjin, Sebang and Dongbang, plus practical scenarios and tax notes for foreign investors.

KCTC 009070 Korea stocks
ACIW ACI Worldwide Stock Outlook 2026: Payments Plumbing, Free Cash Flow, and the Growth Debate

ACIW ACI Worldwide Stock Outlook 2026: Payments Plumbing, Free Cash Flow, and the Growth Debate

An in-depth 2026 outlook on ACI Worldwide (ACIW), the mission-critical payments software vendor for banks, merchants, and billers. We cover the switching-cost moat, the license-to-SaaS transition and lumpy revenue, real-time payments tailwinds from FedNow and ISO 20022, the free cash flow versus growth debate, competition, and how to position it in a U.S. portfolio.

ACIW ACI Worldwide payments software
Namsun Aluminum (KRX 008350) Stock Outlook 2026: The Extrusion Business and the Political-Theme Whipsaw

Namsun Aluminum (KRX 008350) Stock Outlook 2026: The Extrusion Business and the Political-Theme Whipsaw

Namsun Aluminum (KRX 008350) 2026 stock outlook for global investors. A qualitative deep dive into the aluminum extrusion core business (construction window frames and curtain walls plus automotive lightweighting parts), its place inside the SM Group, the materials cycle and construction and auto end-markets, and the extreme volatility that comes from being one of Korea's best-known political-theme stocks.

Namsun Aluminum 008350 Korea stocks